Diffusion Pharmaceuticals (NASDAQ:DFFN) Receives New Coverage from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a report issued on Saturday morning. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Up 1.0 % NASDAQ:DFFN opened at $2.92 on Friday. Diffusion Pharmaceuticals has a 52 week low of $2.76 and a 52 week high of […]